Medline Inc.
Medline Inc. (MDLN) Stock Overview
Explore Medline Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
40.4B
P/E Ratio
29.95
EPS (TTM)
$0.69
ROE
0.08%
MDLN Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Medline Inc. (MDLN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 69.31, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $179.81.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 29.95 and a market capitalization of 40.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.